American Society of Hematology, 2025 (ASH) 7 - 9 December 2025

HIBISCUS 2 (Trial-in-Progress): A Global, Phase 3, Randomized, Double-Blind, Placebo Controlled Study Evaluating the Efficacy and Safety of Etavopivat in Adolescents and Adults with Sickle Cell Disease

Authors :

Pavithra Dhayakar¹, Eric Wu²

Affiliations

View Details Hide Details

PDF default button label

Keywords

Sickle Cell Disease

Congress poster

Etavopivat